Published in Nanomedicine on May 08, 2015
Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol (1981) 6.84
Mechanisms of cancer cell invasion. Curr Opin Genet Dev (2005) 3.47
Unraveling the role of proteases in cancer. Clin Chim Acta (2000) 2.27
Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture. Cancer Res (1990) 1.78
Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst (1995) 1.68
Endocrine treatment of breast cancer in women. Endocr Rev (1990) 1.44
Growth factors in breast cancer. Endocr Rev (1995) 1.37
Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol (1994) 1.36
Extracellular proteases as targets for treatment of cancer metastases. Chem Soc Rev (2004) 1.26
Wafer-scale fabrication of patterned carbon nanofiber nanoelectrode arrays: a route for development of multiplexed, ultrasensitive disposable biosensors. Biosens Bioelectron (2009) 1.16
Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Biochemistry (1997) 1.16
Cathepsin B: a potential prognostic marker for inflammatory breast cancer. J Transl Med (2011) 1.15
Endocrine therapy for advanced breast cancer: a review. Breast Cancer Res Treat (1992) 1.03
Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer. Cancer (1994) 0.99
Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors. Bioorg Med Chem Lett (2012) 0.98
Characterization of carbon nanofiber electrode arrays using electrochemical impedance spectroscopy: effect of scaling down electrode size. ACS Nano (2010) 0.94
Prognostic factors: rationale and methods of analysis and integration. Breast Cancer Res Treat (1994) 0.93
Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides to define substrate specificity of carboxydipeptidases: assays with human cathepsin B. Anal Biochem (2004) 0.93
Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients. Oncol Lett (2011) 0.92
A theoretical approach to some analytical properties of heterogeneous enzymatic assays. Anal Chem (2004) 0.92
Breast cancer genes: how many, where and who are they? Nat Genet (1992) 0.89
Molecular mechanisms of resistance to tamoxifen therapy in breast cancer. Arch Surg (1993) 0.86
Electrochemical Protease Biosensor Based on Enhanced AC Voltammetry Using Carbon Nanofiber Nanoelectrode Arrays. J Phys Chem C Nanomater Interfaces (2013) 0.84
Alternate antiestrogens and approaches to the prevention of breast cancer. J Cell Biochem Suppl (1995) 0.84
Urine and serum cathepsin B concentrations in the transitional cell carcinoma of the bladder. J Clin Lab Anal (2012) 0.82
Quantitative electrochemical detection of cathepsin B activity in complex tissue lysates using enhanced AC voltammetry at carbon nanofiber nanoelectrode arrays. Biosens Bioelectron (2014) 0.77
The Anti-Amyloid-β and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule. J Alzheimers Dis (2017) 0.75